Published in

Elsevier, Journal of Comparative Pathology, 1(146), p. 82

DOI: 10.1016/j.jcpa.2011.11.147

Links

Tools

Export citation

Search in Google Scholar

Expression of Ki67, BCL-2 and COX-2 in Canine Cutaneous Mast Cell Tumours: Correlations with Grading and Prognosis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Introduction: Histological grading and cell proliferation markers are typically used to predict post-surgical prognosis of cutaneous mast cell tumours (MCTs). Material and methods: In the present study, sixty MCTs underwent histological evaluation, grading, immunohistochemistry and total RNA isolation by Real Time RT-PCR, for Ki-67, Bcl-2 and Cox-2. Results: Ki-67 protein was significantly associated with tumour grade and prognosis. Bcl-2 mRNA was associated with the tumour grade and prognosis: the probability of dying for dogs with mRNA > = 0.22 was 5 times higher than dogs with a lower value. The Cox-2 protein was expressed in 51 out of 60 MCTs (85%), and a significant increase in the gene expression was observed, but no association with tumour grade and prognosis was detected. Discussion: These results confirm the prognostic role of Ki-67 protein, and suggest the possible role of Bcl-2 gene in MCT progression. The Cox-2 mRNA up-regulation and the protein expression would suggest a role of Cox-2 in MCTs pathogenesis. Further investigations are required to evaluate the prognostic and therapeutic implications of Cox-2 expression in canine MCTs.